ArticleArtificial organs2025
Ghost Cells as a Two-Phase Blood Analog Fluid-Optical Thrombus Growth Detection Using Particle Image Velocimetry.
Article in Artificial organs, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundIn vitro thrombosis tests for mechanical circulatory support systems lack standardized ISO guidelines. A major limitation of current approaches is the absence of continuous thrombus monitoring, as terminated experiments at a single time point fail to capture the dynamic nature of thrombus formation. However, spatially resolved thrombus formation and its underlying dynamics are crucial for the optimization of mechanical circulatory support systems.
methodsIn this study, we present a high-resolution thrombus monitoring approach using particle image velocimetry with a thrombogenic, two-phase blood analog fluid, designated as "ghost blood". Ghost blood consists of plasma and ghost cells, which are hemoglobin-depleted erythrocytes. We validate and quantify the particle image velocimetry with ghost blood and use this combination to monitor thrombus growth.
resultsThe validation demonstrated velocity fields in the FDA-pump are consistent with existing literature, confirming the usability of ghost blood in particle image velocimetry. The use range of ghost blood is quantified as a formula to determine the maximum possible optical penetration depth. Finally, thrombus growth was successfully monitored in the FDA-pump.
conclusionIn this proof of principle study, we grew a thrombus in the FDA-pump and were able to monitor its growth from a first thrombus thread to a complete obstruction of the flow. This approach enables both the localization and the temporal growth of the thrombus to be visualized and thereby provides a foundation for future advancements in thrombosis assessment and the optimization of mechanical circulatory support systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.